OTCMKTS:BNOEF

Bionomics - BNOEF Stock Forecast, Price & News

$0.02

0.00 (0.00%)

(As of 02/3/2023 12:00 AM ET)

Add

Compare

Today's Range: $0.02
▼
$0.02
50-Day Range: $0.02
▼
$0.04
52-Week Range: $0.01
▼
$0.07

Volume: N/A
Average Volume: 21,030 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Bionomics (OTCMKTS:BNOEF) Stock

Bionomics Ltd. is a clinical stage biopharmaceutical company. It engages in the development of novel drug candidates focused on the treatment of serious central nervous system disorders. The company was founded in 1996 and is headquartered in Eastwood, Australia.

Receive BNOEF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bionomics and its competitors with MarketBeat's FREE daily newsletter.

BNOEF Stock News Headlines

December 15, 2022 | marketwatch.com

Bionomics Names Spyridon Papapetropoulos as President, CEO

December 15, 2022 | finance.yahoo.com

Bionomics appoints Spyridon “Spyros” Papapetropoulos as President and Chief Executive Officer

February 4, 2023 | Tradewins (Ad)

Know Your Profit Potential BEFORE You Trade!

I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now!

November 21, 2022 | nz.finance.yahoo.com

Bionomics Limited Announces Closing of US$5 Million Underwritten Offering of American Depositary Shares in the United States

November 17, 2022 | marketwatch.com

Bionomics Shares Drop 18% After ADS Offering Prices

October 18, 2022 | seekingalpha.com

Bionomics receives R&D tax incentive refund for FY22 of A$4.6M

September 21, 2022 | technews.tmcnet.com

Bionomics to Host KOL Webinar on BNC210 and Social Anxiety Disorder

January 3, 2022 | marketwatch.com

Bionomics Phase 2 Study for Social Anxiety Begins

February 4, 2023 | Tradewins (Ad)

Know Your Profit Potential BEFORE You Trade!

December 26, 2021 | nasdaq.com

Bionomics Ltd. - ADR Shares Near 52-Week Low - Market Mover

November 24, 2021 | markets.businessinsider.com

Australian biotech Bionomics files for IPO with plans to list on Nasdaq

November 23, 2021 | finance.yahoo.com

Bionomics Files Registration Statement for Proposed Initial Public Offering in the United States

September 24, 2021 | fool.com.au

These 3 ASX Healthcare shares have soared over 10% today - The Motley Fool Australia

September 13, 2021 | streetinsider.com

Novamind to Serve as Research Site for Karuna Therapeutics Late-Stage Clinical Trial - StreetInsider.com

July 30, 2021 | finance.yahoo.com

Cyclerion Therapeutics Reports Second Quarter 2021 Financial Results and Corporate Update - Yahoo Finance

July 9, 2021 | finance.yahoo.com

Novamind Selected as Research Site for Bionomics' PTSD Clinical Trial - Yahoo Finance

July 6, 2021 | finance.yahoo.com

Bionomics Initiates Phase 2b ATTUNE Study of BNC210 in PTSD

May 12, 2021 | seekingalpha.com

Bionomics Finds A Second Bow To Its Antianxiety Drug BNC210

May 10, 2021 | finance.yahoo.com

Bionomics BNC210 Expansion into Social Anxiety Disorder

April 13, 2021 | finance.yahoo.com

Novamind Increases Strategic Investment in Bionomics

March 8, 2021 | msn.com

Up almost 1000% in 1 year, the Bionomics (ASX:BNO) share price moves higher

February 27, 2021 | proactiveinvestors.com.au

Bionomics' positive pharmacokinetic results confirms it can begin second Phase 2 study to treat PTSD

February 26, 2021 | proactiveinvestors.com

Bionomics' positive pharmacokinec results confirms it can begin second Phase 2 study to treat PTSD

February 14, 2021 | seekingalpha.com

Bionomics Springs Back To Life

February 11, 2021 | finance.yahoo.com

Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial

February 10, 2021 | finance.yahoo.com

$16 Million Capital Raise to Progress Bionomics BNC210 PTSD Trial

February 9, 2021 | fool.com.au

Why the Bionomics (ASX:BNO) share price is climbing today

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive BNOEF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bionomics and its competitors with MarketBeat's FREE daily newsletter.

BNOEF Company Calendar

Today: 2/04/2023
Fiscal Year End: 6/30/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Noncommercial research organizations
Sub-Industry: N/A
Sector: Medical
Current Symbol: OTCMKTS:BNOEF
CUSIP: N/A
CIK: N/A
Web: www.bionomics.com.au
Phone: (188) 150-7400
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 1.58

Key Executives

Spyros Papapetropoulos
President, Chief Executive Officer & Director

Adrian Hinton
Chief Financial Officer

Liz Doolin
Vice President-Clinical Development

Connor Bernstein
Vice President-Strategy & Corporate Development

Suzanne Grace Irwin
Secretary

Key Competitors

View All Competitors

BNOEF Stock - Frequently Asked Questions

How have BNOEF shares performed in 2023?: Bionomics' stock was trading at $0.0360 at the beginning of 2023. Since then, BNOEF stock has decreased by 34.0% and is now trading at $0.0238.
View the best growth stocks for 2023 here.
Are investors shorting Bionomics?: Bionomics saw a decrease in short interest in the month of January. As of January 15th, there was short interest totaling 37,800 shares, a decrease of 67.6% from the December 31st total of 116,500 shares. Based on an average daily trading volume, of 326,600 shares, the short-interest ratio is currently 0.1 days.
View Bionomics' Short Interest.

What is Bionomics' stock symbol?: Bionomics trades on the OTCMKTS under the ticker symbol "BNOEF."
How do I buy shares of Bionomics?: Shares of BNOEF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Bionomics' stock price today?: One share of BNOEF stock can currently be purchased for approximately $0.02.
How can I contact Bionomics?: The official website for the company is www.bionomics.com.au. The company can be reached via phone at (188) 150-7400.

This page (OTCMKTS:BNOEF) was last updated on 2/4/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial